NCI Outstanding Investigator Award (R35 Clinical Trial Optional)

The National Cancer Institute (NCI) has an open call for applications for the Outstanding Investigator Award (R35). The grant can be used towards any area of cancer research and is designed to provide long-term support for skilled investigators who have achieved significant success in cancer research.

The underlying goal of the Outstanding Investigator Award is to motivate investigators to undertake bolder research, develop new techniques, or explore unconventional paths of inquiry in their cancer research. The award is unique in that it allows institutions to nominate qualified Program Directors or Principal Investigators for the award.

By providing extended funding stability, the NCI hopes to stimulate researchers' enthusiasm to embark on ambitious projects with the potential to drastically impact cancer research. This may include pioneering new areas of study, expanding on existing findings in innovative ways, or developing new applications that could lead to significant advancements in the biomedical, behavioral, or clinical aspects of cancer research. In essence, the NCI seeks research that could potentially lead to a game-changing breakthrough in the fight against cancer.